Topic: SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
Type of Action: CSA
Duration: 48 months
Start date: 1 Jan 2020
Grant agreement: 874694
Web: not yet available
Total request Grant by Consortium: €1,691,437.50
Total request Grant by BBMRI-ERIC: €219,687.50
Linked Third Parties/BBMRI-ERIC Framework Agreement: none
Benefit/tasks for BBMRI-ERIC: BBMRI-ERIC is involved in WP1 (Mapping of PM policies and programmes in Europe and China), WP2 (Knowledge synthesis on the identification, transferability and scaling up of international standards in personalized medicine), WP3 (Foster research collaboration between EU and China) including leading Task 3.3 (Setting a concrete collaboration scenario on Biobanks), WP4 (Communication, dissemination, outreach and exploitation) and WP5 (Project Management)
Personalised Medicine (PM) approaches, thanks to the latest technological advances notably in the fields of biomedical and digital technologies, prove their potential to improve healthcare and underpin more efficient and sustainable health systems. PM is at the top of the European Commission research agenda, with funding devoted to projects along the entire value chain.
In China, PM is attracting massive interest, with the government capitalising on its expertise in biotechnology, computing hardware and the ability to put in place the infrastructures for supporting large bioinformatics projects. Turning PM into an opportunity for all citizens and patients requires the engagement of all stakeholders, in order to define common research and development approaches, standards, and priorities, and to scale up the collaboration at the International level.
In order to respond to these challenges, the EU supports actions developed within the International Consortium for Personalised Medicine (ICPerMed). IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed consortium of European and Chinese stakeholders towards a common approach of PM research, innovation, development and implementation involving policy makers and healthcare beneficiaries, by:
IC2PerMed is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874694.